About Airis Pharma Private Limited
Data last updated:
Airis Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC089550. Its GSTIN is 36AALCA8930B1ZR (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.52 Cr. It is led by directors including Venkata Bhattaram Chandra Sekhar and Mohan Reddy Patalolla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.06 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹77.32 Lakh (net margin -8.5%) and EBITDA of ₹76.64 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 92% over five years.
The company has about 47 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: airis PHARMA. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending. The company has 5 deals on record (3 funding rounds, 2 rights issues), with disclosed funding of ₹18.66 Cr; the latest was in February 2020. Its 4 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 3 larger and 1 smaller; the largest is Zasya Life Sciences Private Limited with revenue of ₹9.37 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website airispharma.com.
Company details
CIN history
Airis Pharma has one previous CIN (Corporate Identification Number): U24232AP2013PTC089550. The current CIN is U24232TG2013PTC089550, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC089550 | Current |
| U24232AP2013PTC089550 | Previous |
Contact details
Airis Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is airispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 64 And 65 Survey No. 342 Aleap Industrial Estate Gajularamaram V, Illage, Hyderabad, Telangana, India – 500078
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Airis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Airis Pharma operates one associated brand: airis PHARMA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and supplies generic drugs including oral solids and injectables internationally. | airispharma.com |
Business activity
The main business activity of Airis Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Airis Pharma Private Limited, buy the company report.
Financials of Airis Pharma Private Limited
FY 2024 filings availableAiris Pharma Private Limited reported revenue of ₹9.06 Cr (up 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 92% over five years, including 29% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹77.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | -8.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Airis Pharma Private Limited, buy the company report.
Board of directors of Airis Pharma Private Limited
Airis Pharma has 7 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Bhattaram Chandra Sekhar | Director | 21 Jul 2025 | 1 Years 3 Months | Current |
| Mohan Reddy Patalolla | Director | 16 Jan 2017 | 9 Years 9 Months | Current |
| Ganji Kishore Kumar Also directs: Isv Management Consultancy LLP, Earthbound Organic Farms Private Limited, Smart Agro Food Park Private Limited and 5 more | Director | 30 Aug 2013 | 13 Years 1 Months | Current |
| Ajoy Pavan Kumar Koppolu Yerakaliah | Director | 30 Aug 2013 | 13 Years 1 Months | Current |
| Gantla Shailaja | Director | 21 Sep 2020 | 6 Years 1 Months | Current |
| Srilalitha Bhattaram | Director | 21 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Airis Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zasya Life Sciences Private Limited | ₹9.37 Cr (FY 2025) | 3.0% | Amipura, Gujarat, India | |||
| Receps Limited | ₹9.2 Cr (FY 2025) | 65.0% | Hyderabad, Telangana, India | |||
| Taraasian Drugs Private Limited | ₹9.17 Cr (FY 2025) | 21.0% | Aurangabad, Maharashtra, India | |||
| Airis Pharma Private Limitedthis company | ₹9.06 Cr (FY 2024) | -₹77.32 Lakh | -8.5% | 29.0% | 47 | Hyderabad, Telangana, India |
| Indivirtus Healthcare Services Private Limited | ₹8.76 Cr (FY 2025) | 8.0% | Chandigarh, India |
To see the full peer comparison of Airis Pharma Private Limited, buy the company report.
Auditor
Airis Pharma Private Limited is audited by GPHK & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GPHK & Associates | FY 2022 | 0008053S |
Shareholding
The shareholding of Airis Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Airis Pharma Private Limited, buy the company report.
Deals & funding
Airis Pharma Private Limited has 5 deals on record (3 funding rounds, 2 rights issues), with disclosed funding of ₹18.66 Cr; the latest was in February 2020.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2020 | Rights issue | ₹8.44 Cr | Investors: 2 individuals |
| Mar 2018 | Rights issue | ₹10.22 Cr | Investors: 3 individuals |
| Apr 2017 | Funding round | ₹5.23 Cr | Investors: 3 individuals |
| Aug 2015 | Funding round | ₹8.61 Cr | Investors: 3 individuals |
| Mar 2014 | Funding round | ₹4.81 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Airis Pharma Private Limited has 3 court cases on record: 2 filed by Airis Pharma, 1 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
| High courts | 1 | 0 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.A.P.) | Filed by the company against Biocon Pharma Ltd | Pending |
| High Court, KARNATAKA | Interim or miscellaneous application | Filed by the company against Biocon Pharma Ltd | Disposed |
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Biocon Pharma Limited | Disposed |
To see the full case history of Airis Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Airis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Airis Pharma Private Limited has a workforce of 47 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Airis Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AALCA8930B1ZR | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Airis Pharma Private Limited, buy the company report.
Recent activity
Airis Pharma Private Limited has 17 board changes on record since 2013: 8 appointments and 9 cessations. The latest: Bhagwant Reddy Gantla ceased to be Director on 05 Jan 2026.
8 earlier events are in the company report.
Frequently asked questions
Airis Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 19 August 2013 (13+ years old) and is registered under CIN U24232TG2013PTC089550.
Airis Pharma has 7 current directors:
- Venkata Bhattaram Chandra Sekhar - Director
- Mohan Reddy Patalolla - Director
- Ganji Kishore Kumar - Director
- Ajoy Pavan Kumar Koppolu Yerakaliah - Director
- Gantla Shailaja - Director
- Srilalitha Bhattaram - Director
- Suchritha Reddy Patlolla - Director
The latest financial statements of Airis Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Airis Pharma is 36AALCA8930B1ZR, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Airis Pharma is U24232TG2013PTC089550. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Airis Pharma has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Airis Pharma was incorporated on 19 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Airis Pharma has 5 deals on record (3 funding rounds, 2 rights issues), with disclosed funding of ₹18.66 Cr; the latest was in February 2020.
The peers of Airis Pharma by revenue are Zasya Life Sciences Private Limited, Receps Limited, Taraasian Drugs Private Limited, Indivirtus Healthcare Services Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Bhagwant Reddy Gantla ceased to be Director on 05 Jan 2026. Jakkampudi Venkateswara Rao ceased to be Director on 05 Jan 2026. Shanthakumari Ganji ceased to be Director on 05 Jan 2026. Airis Pharma has 17 board changes on record in total.
Airis Pharma can be reached through the website airispharma.com. Its registered office is in Hyderabad, Telangana, India.